In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chicago Supplement Firm Runs Out Of Chances To Correct GMP, Label Violations

This article is powered by The Rose Sheet

Executive Summary

"Despite repeated promises to fix the problems, Defendants have not done so. Accordingly, the United States now seeks a permanent injunction to bring Defendants’ operations into compliance with the law," US attorneys say in a complaint. Global Marketing Enterprises enters consent decree with FDA requiring that before resuming manufacturing and distributing supplements, it implement remedial measures to brings its operations into compliance.

You may also be interested in...



Own-Label Multi-Level Marketer 'Repeatedly Warned' And 'Dissolved,' But Distributed Supplements Until Shut Down

DoJ complained filed Tennessee federal court also says the firm, identified as Basic Reset and as Biogenyx in Hendersonville, TN, distributed a noncompliant device branded Energy FX, a pendant for pets and people that emits "positive healthy energy" that "overrides the negative [electromagnetic frequencies] pollution."

Undisclosed Allergen, Caffeine Claims Prompt Supplement Recalls

Firms marketing supplements found to contain steroid ingredients also are recalling products.

Iowa Select Herbs Runs Out Of Warnings

The firm’s owners “are well aware that their conduct violates the law and that continued violations could lead to regulatory action,” DoJ says in complaint requesting a permanent injunction to prohibit it from making and distributing supplements until it complies with FDA GMP and labeling regulations.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel